In the combined cohort, the prevalence of SULF2, JPH3, PCDH20, and p16 methylation were all significantly higher in males with CMH compared to males without CMH (p < 0.05, all analyses). Here, JPH3 is linked to hypertrophic cardiomyopathy 1.